Product
IM-250
1 clinical trial
1 indication
Indication
Herpes Simplex VirusClinical trial
Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-01-30